About Annexon (ANNX)
Annexon, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of therapies for patients with classical complement-mediated disorders of the body, brain and eye. The Company’s pipeline is based on its platform technology... Read more
- USD2.46
- USD2.54
- USD2.42
- USD8.40
- -12.30%
- --
- 863.45k
- 1.30M
- 285M
- 2.30
- -58.90%
Stock News
yesterday
Jim Cramer says holding Home Depot stock is a good idea
CNBC
yesterday
Micron gets boost with surging AI memory-chip sales; shares jump on earnings beat
MarketWatch
yesterday
The 10 most expensive places in the U.S. to start a new business, report finds
CNBC
yesterday
We're adding a well-known tech stock to our Bullpen watchlist after Nvidia's big AI event
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
